The S&P 500 soared more than 32% in 2013, and several big pharma companies, namely Bristol-Myers Squibb (NYSE:BMY), AbbVie (NYSE:ABBV), Roche (OTC:RHHB.Y), Johnson & Johnson (NYSE:JNJ), and AstraZeneca (NYSE:AZN) also performed extraordinarily well. The following slideshow reveals why these companies beat out their big pharma peers and what drove their strong performances in 2013.
Motley Fool Returns
Stock Advisor S&P 500
Stock Advisor launched in February of 2002. Returns as of 09/21/2020.Join Stock Advisor
Cumulative Growth of a $10,000 Investment in Stock Advisor Calculated by Time-Weighted Return